Pharmafile Logo
Pharmafocus logo
Advanced Search

vaccines

Showing 15 posts of 193 posts found.

UK children recruited for H1N1 vaccine trials

October 2, 2009
Research and Development, Sales and Marketing h1n1, paediatric, vaccines

The UK has commenced a two-week swine flu vaccine trial, a month ahead of its planned programme to vaccinate 11 …

News

GSK faces fresh US delays over Cervarix

September 30, 2009
Sales and Marketing Cervarix, GSK, vaccines

GSK faces new delays in the US over the approval of its cervical cancer vaccine Cervarix, after the FDA failed …

News

J&J buys stake in vaccines firm Crucell

September 29, 2009
Sales and Marketing Crucell, JJ, vaccines

Johnson & Johnson has acquired an 18% stake in Netherlands-based vaccines firm Crucell, and the two companies will work together …

News

WHO welcomes pandemic vaccine donations to developing world

September 21, 2009
Sales and Marketing h1n1, hc, vaccines

The World Health Organisation has applauded donations of H1N1 vaccine made by the US, Australia, Brazil, France, Italy, New Zealand, …

News

Gardasil cleared in FDA safety review

August 27, 2009
Research and Development, Sales and Marketing Gardasil, US, vaccines

News

‘No shortcuts’ on H1N1 vaccine safety says GlaxoSmithKline

August 20, 2009
Research and Development, Sales and Marketing GSK, h1n1, vaccines

GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …

News

GSK starts first trials for H1N1 vaccine in Germany

August 17, 2009
Research and Development, Sales and Marketing GSK, h1n1, vaccines

GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …

News

Sanofi buys Indian vaccines firm

July 27, 2009
Research and Development, Sales and Marketing Asia, Sanofi-Aventis, vaccines

News

Poor antigen yields limiting H1N1 vaccine supplies, says WHO

July 15, 2009
Manufacturing and Production, Research and Development h1n1, vaccines

Inadequate production capacity means that the poorest countries in the world will be denied access to vaccines for H1N1 influenza, …

News

WHO gives Cervarix green light for use in developing nations

July 10, 2009
Research and Development, Sales and Marketing Cervarix, vaccines

News

Asia Pacific vaccines market requires flexible, targeted portfolios

July 2, 2009
Research and Development, Sales and Marketing Asia, vaccines

Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …

News

Cervical cancer awareness campaign targets GPs and nurses

June 26, 2009
Medical Communications, Sales and Marketing NHS, vaccines

GPs and practice nurses are to be targeted in a government awareness campaign to ensure cervical cancer is spotted earlier …

News

Merck Serono breast cancer vaccine enters phase III

June 22, 2009
Research and Development Cancer, Merck Serono, Stimuvax, vaccines

Merck Serono is to begin a global phase III study for its therapeutic cancer vaccine Stimuvax in patients with advanced, …

News

Sanofi to donate millions of flu vaccines for developing world

June 18, 2009
Research and Development Sanofi-Aventis, h1n1, vaccines

Sanofi-Aventis is to set aside 100 million flu vaccine doses for the developing world in order to fight the emerging …

News

Companies poised for swine flu vaccine drive

May 29, 2009
Research and Development, Sales and Marketing US, h1n1, vaccines

Pharmaceutical manufacturers now have access to the swine flu seed virus that can be used to start full-blown production of …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026